FY27 Revenue Target: 256 Crore
Management confirmed being in line with the previously given revenue guidance of approximately 256 crore for FY27, representing ~48% growth over FY26's 172.9 crore.
QMSMEDICALALLIED / guidance tracker
Keep management guidance in view.
Qmsmedicalallied · forward-looking guidance across the available source record.
Research layer active
Guidance tracker
What management said would happen.
revenue
Services Revenue to Double to 100 Crore
Management targets doubling service segment revenue from ~50 crore in FY26 to 100 crore in FY27, driven by new patient service program contracts and GLP-1 therapy launches by pharma clients.
Camp Revenue: 18-20 Crore in FY27
Revenue from healthcare camps expected to grow from ~13 crore in FY26 to 18-20 crore in FY27, with mixed camp pricing models based on type and patient volume.
EBITDA Margins: 18-19% Target
Management maintains confidence in achieving 18-19% EBITDA margins going forward, with service segment margins at 25% and product segment margins at 10-12%, as investments in new programs become productive.